Related Articles
Research
Canaccord Genuity Initiates BridgeBio Pharma at Buy With $104 Price Target
BridgeBio Pharma (BBIO) has an average rating of buy and mean price target of $104.64, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$BBIO
Research
HC Wainwright Initiates Upstream Bio at Buy With $36 Price Target
Upstream Bio (UPB) has an average rating of buy and mean price target of $45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$UPB
Research
RBC Upgrades SSR Mining to Outperform From Sector Perform, Lowers Price Target to $40 From $45
SSR Mining (SSRM) has an average rating of buy and mean price target of $43.75, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$SSRM